Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Back to Our thinking

English
中文
Deutsch
Español
Français
日本語
Português

News

Federal judge says Meta is not a monopoly, ending FTC’s long-running antitrust case against the social media company

02 December 2025

News

SFO guidance on evaluating a corporate compliance programme

27 November 2025

News

FDA announces “plausible mechanism” approval pathway for certain personalized therapies, with few details

13 November 2025

News

Financial crime: UK FCA shares findings from review of firms’ risk assessment processes and controls

13 November 2025

News

UK High Court: landmark decision on copyright and Gen AI

05 November 2025

News

FDA rethinks need for comparative efficacy studies for certain biosimilars

31 October 2025

News

FDA readies for QMSR implementation with draft QMS information guidance: What manufacturers need to know

31 October 2025

News

Domain Name News: October 2025

30 October 2025

Insights and Analysis

Crypto regulation and enforcement: Key risks, trends, and compliance priorities

30 October 2025

Insights and Analysis

Life Science and Health Care Law Update Q3

27 October 2025

News

AI Growth Lab: UK champions AI innovation with regulatory sandbox proposal

23 October 2025

News

Panelists observe FDA sea changes in inspections, manufacturing, and drug & device reviews

20 October 2025

Digital Client Solutions

Empowering you to lead change through our digital solutions.

Learn more

Our thinking

News

News

News

News

News

News

News

News

Insights and Analysis

Insights and Analysis

News

News

No results found